12 results
Original and Simplified PESI Prediction Rule Test Characteristics for 30-Day Mortality
#EBM #Diagnosis	#EM #IM #PCC	#PESI #sPESI #risk
and Simplified PESI ... Day Mortality #EBM ... #Diagnosis #EM ... #IM #PCC #PESI # ... sPESI #risk #score
Original and Simplified PESI PulmonaryEmbolism #Diagnosis #EM #IM #PCC #PESI #sPESI #risk #score #PE #Table
and Simplified PESI ... PulmonaryEmbolism #Diagnosis #EM ... #IM #PCC #PESI ... #sPESI #risk #score
Causes of Dyspnea by System #Diagnosis #EM #IM #PCC #Dyspnea #ShortnessOfBreath #Differential #Algorithm #Ddxof
System #Diagnosis #EM ... #IM #PCC #Dyspnea ... Differential #Algorithm #Ddxof
Pleural Effusion - Workup, Diagnostic Algorithm #Diagnosis #EM #IM #PCC #Pleural #Effusion #Transudative #Exudative #Differential #Algorithm
Algorithm #Diagnosis #EM ... #IM #PCC #Pleural ... Lights #Criteria #Ddxof
Pulmonary Embolism Severeity Index - estimates 30d mortality #Diagnosis #Management #EM #IM #PCC #PESI #sPESI #risk
Diagnosis #Management #EM ... #IM #PCC #PESI ... #sPESI #risk #score
Algorithm and Causes of an Elevated Hemidiaphragm #Diagnosis #Radiology #EM #IM #PCC #Elevated #Hemidiaphragm #ElevatedHemidiaphragm #Diaphragm
Diagnosis #Radiology #EM ... #IM #PCC #Elevated ... Differential #Algorithm #Ddxof
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Algorithm for Evaluation of Suspected Pulmonary Embolism #Diagnosis #EM #IM #PCC #PulmonaryEmbolism #Pulmonary #Embolism #DDimer #CTA
Embolism #Diagnosis #EM ... #IM #PCC #PulmonaryEmbolism ... CTA #Algorithm #Ddxof
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM